Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Black Diamond Therapeutics, Inc. - Common Stock
(NQ:
BDTX
)
3.890
-0.090 (-2.26%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Black Diamond Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
September 05, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 11, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Where Black Diamond Therapeutic Stands With Analysts
July 14, 2023
Via
Benzinga
$4.7M Bet On Black Diamond Therapeutics? Check Out These 3 Stocks Insiders Are Buying
July 10, 2023
Although US stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
What 4 Analyst Ratings Have To Say About Black Diamond Therapeutic
June 28, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
July 14, 2023
Via
Benzinga
Nanobiotix, NanoString Technologies And Other Big Stocks Moving Higher In Monday's Pre-Market Session
July 10, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
$1M Bet On Children's Place? Check Out These 3 Stocks Insiders Are Buying
July 07, 2023
Although US stocks closed lower on Thursday, there were a few notable insider trades.
Via
Benzinga
Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 10, 2023
Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the...
Via
Benzinga
$5M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
July 05, 2023
Although US stocks closed slightly higher on Monday, there were a few notable insider trades.
Via
Benzinga
Genuine Monotherapy Approach In EGFRm NSCLC: Analyst Upgrades Switches To Buy On Black Diamond Therapeutics
June 30, 2023
Tuesday, Black Diamond Therapeutics Inc (NASDAQ: BDTX) announced initial clinical data from the dose escalation portion of Phase 1 clinical study of BDTX-1535 for non-small cell lung cancer (NSCLC)
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
June 30, 2023
Via
Benzinga
$1.5M Bet On ONEOK? Check Out These 3 Stocks Insiders Are Buying
June 30, 2023
Although US stocks closed mostly higher on Thursday, there were a few notable insider trades.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 30, 2023
It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today!
Via
InvestorPlace
Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock
June 29, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Why Shares of Black Diamond Therapeutics Skyrocketed This Week
June 29, 2023
The company announced positive early-trial news for non-small cell lung cancer.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 29, 2023
Via
Benzinga
Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket
June 29, 2023
Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 29, 2023
We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today!
Via
InvestorPlace
Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock
June 28, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 28, 2023
Via
Benzinga
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 28, 2023
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.
Via
Benzinga
Tesla And Nvidia Lead The Charge As Stocks Surge: Top Trends Of The Day
June 27, 2023
Via
Benzinga
Nasdaq Jumps Over 200 Points; TD Synnex Posts Downbeat Results
June 27, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.73% to 33,959.64 while the NASDAQ rose 1.75% to 13,569.42....
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023
June 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 27, 2023
Via
Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
Via
Benzinga
Black Diamond Therapeutics’ (NASDAQ: BDTX) BDTX-1535 Proves Promising for EGFR Mutated NSCLC and GBM
June 27, 2023
Black Diamond Therapeutics has announced encouraging initial data from a Phase 1 study of BDTX-1535, an investigational fourth-generation EGFR MasterKey
Via
Spotlight Growth
Dow Surges Over 100 Points; Walgreens Lowers Earnings Forecast
June 27, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Tuesday. The Dow traded up 0.39% to 33,845.82 while the NASDAQ rose 0.55% to 13,408.91. The S&P 500,...
Via
Benzinga
Black Diamond Therapeutics Inc. (NASDAQ: BDTX) Leading the Way in Tuesday Trading Based on Percentage Gain
June 27, 2023
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit